Vaccine for the prevention of breast cancer recurrence

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/00 (2006.01) A61K 38/19 (2006.01) A61P 35/00 (2006.01) A61P 37/04 (2006.01)

Patent

CA 2744035

Provided are methods to induce and maintain a protective cytotoxic T- lymphocyte response to a peptide of the HER/neu oncogene, GP2, with the effect of inducing and maintaining protective or therapeutic immunity against breast cancer in a patient in clinical remission, including patients having low to intermediate levels of HER2/neu expression. The methods comprise administering to the patient an effective amount of a vaccine composition comprising a pharmaceutically acceptable carrier, an adjuvant such as GM-CSF, and the GP2 peptide. The methods may further comprise administering a periodic booster vaccine dose as needed due to declining GP2-specific T cell immunity. Also provided are vaccine compositions for use in the methods.

La présente invention concerne des procédés pour induire et maintenir une réponse de lymphocytes T cytotoxiques protectrice à un peptide de loncogène ?ER/neu, GP2, ayant pour effet dinduire et maintenir une immunité protectrice ou thérapeutique contre le cancer du sein chez une patiente en rémission clinique, comprenant des patientes ayant des taux faibles à intermédiaires dexpression de HER2/neu. Les procédés comprennent ladministration à la patiente dune quantité efficace dune composition de vaccin comprenant un véhicule pharmaceutiquement acceptable, un adjuvant tel que GM-CSF, et le peptide GP2. Les procédés peuvent comprendre en outre ladministration dune dose de vaccin de rappel périodique comme requis en raison dune diminution de limmunité de lymphocytes T spécifique à GP2. La présente invention concerne en outre des compositions de vaccin pour utilisation dans les procédés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Vaccine for the prevention of breast cancer recurrence does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vaccine for the prevention of breast cancer recurrence, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine for the prevention of breast cancer recurrence will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1811948

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.